Olmetime H 20 Tablet is a prescription drug, available for use as Tablet. Secondary and off-label uses of Olmetime H 20 Tablet have also been mentioned below.
The right dosage of Olmetime H 20 Tablet depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
The most common side effects of Olmetime H 20 Tablet are Upper respiratory tract infection. Besides the aforementioned side effects, there are other adverse effects of Olmetime H 20 Tablet as well, which are listed below. Usually, these side effects of Olmetime H 20 Tablet go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Olmetime H 20 Tablet's effect is Severe during pregnancy and Mild for lactating mothers. It is important to know if Olmetime H 20 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Olmetime H 20 Tablet related warnings section.
Individuals suffering from medical conditions like Asthma, Allergy, Kidney Disease must refrain from the use of Olmetime H 20 Tablet since this can cause severe adverse effects. The section on Olmetime H 20 Tablet contraindications lists all such conditions.
Drug interactions for Olmetime H 20 Tablet have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Olmetime H 20 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Olmetime H 20 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Olmetime H 20 Tablet is used -
Moderate
Mild
Common
Is the use of Olmetime H 20 Tablet safe for pregnant women?
Olmetime H shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Olmetime H 20 Tablet safe during breastfeeding?
Olmetime H may have very limited harmful effects for breastfeeding women.
What is the effect of Olmetime H 20 Tablet on the Kidneys?
Very few cases of side effects of Olmetime H on kidney have been reported.
What is the effect of Olmetime H 20 Tablet on the Liver?
Olmetime H has very mild side effects on the liver.
What is the effect of Olmetime H 20 Tablet on the Heart?
Very few cases of side effects of Olmetime H on the heart have been reported.
Olmetime H 20 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Olmetime H 20 Tablet unless your doctor advises you to do so -
Is this Olmetime H 20 Tablet habit forming or addictive?
No, you will not get addicted to Olmetime H 20 Tablet.
Interaction between Food and Olmetime H 20 Tablet
Some foods when eaten with Olmetime H 20 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Olmetime H 20 Tablet
Taking Olmetime H 20 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173